Background Treatment strategies for Crohn’s disease (CD) suppress diverse inflammatory pathways but many patients remain ...

CATUMAXOMAB BECOMES THE ONLY APPROVED DRUG THERAPY FOR MALIGNANT ASCITES, A RARE AND DEBILITATING COMPLICATION OF ADVANCED-STAGE CANCER UNDER A LICENSING AGREEM ...

Inhibiting GLS1 reduced high blood pressure in the right side of the heart of PAH rats and improved various measures of heart ...

This important study focused on characterizing clonally derived MSC populations from the synovium of normal and osteoarthritis (OA) patients, demonstrating their potential to regenerate cartilage in ...

Gene therapies to treat rheumatoid arthritis have evolved slowly, but one is ready to move into human trials and an ...

Monocyte-like macrophage (MLM) accumulation precedes colitis-associated ... Besides the temporal changes, we investigated the differences in proinflammatory markers, myeloid cell subsets and ...

Secretary of State Marco Rubio has frozen all applications for passports with “X” gender markers, an option available to people who don’t identify as male or female that was started in the ...

self-renewing macrophages and from bone marrow-derived progenitors, fostering long lasting local defense. Early inhibition of STAT1 activation, using specific JAK-STAT inhibitors, reduces both RPM ...

According to the new report, the Macrophage Marker Market is estimated to be valued at US$ 256.2 million 2023 to US$ 398.2 million by 2030 at a compounded annual growth rate (CAGR) of 6.5% during the ...